Globus Medical, Inc. NYQ · GMED
Price alert —
Sign in to get a one-time email the moment GMED crosses your price. Free accounts included.
Sign in / create a free accountPrice chart
Loading…
Latest bar · GMED
Momentum reads · latest daily barGreen means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.
Financial overlay · last 12 quarters
The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | $0.8B | $0.1B | $0.2B | $0.2B | 16.4% | 21.3% |
| 2025-12-31 | $0.8B | $0.1B | $0.2B | $0.2B | 17.0% | 21.9% |
| 2025-09-30 | $0.8B | $0.1B | $0.1B | $0.2B | 15.5% | 17.6% |
| 2025-06-30 | $0.7B | $0.2B | $0.1B | $0.0B | 27.2% | 16.5% |
| 2025-03-31 | $0.6B | $0.1B | $0.1B | $0.1B | 12.6% | 16.4% |
| 2024-12-31 | $nanB | $nanB | $nanB | $nanB | nan% | nan% |
Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.
Compare GMED vs peers
Line GMED up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.
Add tickers to compare with GMED
~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.
Earnings replay · last 20 reports
How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.
| Date | EPS actual | EPS est | Surprise | Next-day |
|---|---|---|---|---|
| 2026-05-07 | 1.12 | 0.92 | +21.7% | -8.4% |
| 2026-02-24 | 1.28 | 1.15 | +11.0% | +4.7% |
| 2025-11-06 | 1.18 | 0.78 | +51.1% | +35.9% |
| 2025-08-07 | 0.86 | 0.75 | +14.9% | +8.5% |
| 2025-05-08 | 0.68 | 0.75 | -9.2% | -23.0% |
| 2025-02-20 | 0.84 | 0.75 | +12.2% | -4.6% |
| 2024-11-05 | 0.83 | 0.65 | +28.3% | +9.4% |
| 2024-08-06 | 0.75 | 0.68 | +10.7% | +2.1% |
| 2024-05-07 | 0.72 | 0.57 | +27.0% | +20.2% |
| 2024-02-20 | 0.60 | 0.61 | -1.7% | +1.6% |
| 2023-11-07 | 0.57 | 0.57 | -0.1% | -0.7% |
| 2023-08-03 | 0.63 | 0.59 | +6.2% | -1.9% |
| 2023-05-04 | 0.53 | 0.51 | +4.2% | +3.3% |
| 2023-02-21 | 0.59 | 0.56 | +5.3% | +0.5% |
| 2022-11-08 | 0.50 | 0.52 | -4.0% | -4.2% |
| 2022-08-04 | 0.56 | 0.53 | +4.9% | +6.9% |
| 2022-05-10 | 0.42 | 0.47 | -10.2% | -1.1% |
| 2022-02-17 | 0.49 | 0.47 | +3.8% | -0.1% |
| 2021-11-04 | 0.50 | 0.45 | +10.7% | +1.4% |
| 2021-08-04 | 0.56 | 0.44 | +25.9% | -0.9% |
Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.
Peer comparison · Healthcare
Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| GMED ★ | $10B | 18.0 | 15.0 | 3.4 | 10.5 | 2.2 | 68.5% | 27.0% | 66.7% | 3.26% |
| LLY | $1,051B | 41.8 | 26.3 | 14.6 | 30.1 | 33.8 | 82.8% | 55.5% | 169.9% | 0.87% |
| UNH | $387B | 32.1 | 19.2 | 0.9 | 17.7 | 4.0 | 19.5% | 0.4% | 61.5% | 5.88% |
| JNJ | $609B | 29.3 | 19.7 | 6.2 | 18.4 | 7.5 | 68.1% | 6.6% | -1.0% | — |
| MRK | $315B | 36.0 | 13.2 | 4.8 | 12.1 | 6.9 | 76.7% | 4.9% | — | 4.46% |
| ABBV | $450B | 124.8 | 15.6 | 7.2 | 17.2 | -67.6 | 72.0% | 12.4% | -46.2% | 4.63% |
| PFE | $143B | 19.1 | 8.8 | 2.3 | 7.6 | 1.6 | 74.8% | 5.4% | -10.1% | 8.67% |
| TMO | $198B | 29.2 | 19.5 | 4.4 | 21.1 | 3.8 | 40.9% | 6.2% | 11.3% | 2.79% |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.
Top institutional holders
Top-10 concentration: 33.89%
| Holder | Shares | % out |
|---|---|---|
| Blackrock Inc. | 10,497,414 | 7.73% |
| Janus Henderson Group PLC | 7,623,095 | 5.62% |
| Vanguard Capital Management LLC | 5,032,732 | 3.71% |
| Vanguard Portfolio Management LLC | 4,879,459 | 3.59% |
| Invesco Ltd. | 4,316,654 | 3.18% |
| State Street Corporation | 3,590,372 | 2.64% |
| Sculptor Capital LP | 3,058,000 | 2.25% |
| JPMORGAN CHASE & CO | 2,595,308 | 1.91% |
| Bank of Montreal /CAN/ | 2,307,181 | 1.70% |
| Geode Capital Management, LLC | 2,112,124 | 1.56% |
Insider activity · 90d
0 buys / 1 sells · ratio 0.0 · Finnhub
- Davidar David D M 0
- Davidar David D SELL 510,175 @ $80.76
- Davidar David D M 535,175 @ $26.27
- RHOADS ANN D M 0
- RHOADS ANN D M 40,384 @ $26.27
Analyst estimates
FinnhubWhat Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.
SEC filings
The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.
| Form | Filed | Description | Action |
|---|---|---|---|
| 4 | 2026-06-09 | 4 | view · |
| 4 | 2026-06-08 | 4 | view · |
| 8-K | 2026-06-04 | 8-K | view · |
| 10-Q | 2026-05-07 | 10-Q | view · |
| 8-K | 2026-05-07 | 8-K | view · |
| DEF 14A | 2026-04-24 | DEF 14A | view · |
| 8-K | 2026-03-23 | 8-K | view · |
| 4 | 2026-02-27 | 4 | view · |
| 10-K | 2026-02-24 | 10-K | view · |
| 8-K | 2026-02-24 | 8-K | view · |
| 4 | 2026-02-17 | 4 | view · |
| 4 | 2026-01-23 | 4 | view · |
| 4 | 2026-01-23 | 4 | view · |
| 4 | 2026-01-23 | 4 | view · |
| 4 | 2026-01-23 | 4 | view · |
| 4 | 2026-01-23 | 4 | view · |
| 4 | 2026-01-23 | 4 | view · |
| 4 | 2026-01-23 | 4 | view · |
| 4 | 2026-01-23 | 4 | view · |
| 4 | 2026-01-23 | 4 | view · |
| 4 | 2026-01-23 | 4 | view · |
| 4 | 2026-01-23 | 4 | view · |
| 4 | 2026-01-23 | 4 | view · |
| 4 | 2026-01-23 | 4 | view · |
| 4 | 2026-01-12 | 4 | view · |
| 4 | 2026-01-12 | 4 | view · |
| 8-K | 2026-01-07 | 8-K | view · |
| 4 | 2026-01-05 | 4 | view · |
| 4 | 2025-12-16 | 4 | view · |
| 4 | 2025-12-10 | 4 | view · |
| 4 | 2025-12-03 | 4 | view · |
| 4 | 2025-11-28 | 4 | view · |
| 4 | 2025-11-13 | 4 | view · |
| 4 | 2025-11-13 | 4 | view · |
| 4 | 2025-11-10 | 4 | view · |
| 10-Q | 2025-11-06 | 10-Q | view · |
| 8-K | 2025-11-06 | 8-K | view · |
| 4 | 2025-09-16 | 4 | view · |
| 4 | 2025-08-27 | 4 | view · |
| 4 | 2025-08-27 | 4 | view · |
| 10-Q | 2025-08-07 | 10-Q | view · |
| 8-K | 2025-08-07 | 8-K | view · |
| 8-K | 2025-07-21 | 8-K | view · |
| 8-K | 2025-06-05 | 8-K | view · |
| 8-K | 2025-05-15 | 8-K | view · |
| 10-Q | 2025-05-08 | 10-Q | view · |
| 8-K | 2025-05-08 | 8-K | view · |
| DEF 14A | 2025-04-25 | DEF 14A | view · |
| 8-K | 2025-04-03 | 8-K | view · |
| 4 | 2025-03-28 | 4 | view · |
| 4 | 2025-03-28 | 4 | view · |
| 4 | 2025-03-28 | 4 | view · |
| 4 | 2025-03-28 | 4 | view · |
| 4 | 2025-03-28 | 4 | view · |
| 4 | 2025-03-28 | 4 | view · |
| 4 | 2025-03-28 | 4 | view · |
| 4 | 2025-03-28 | 4 | view · |
| 4 | 2025-03-28 | 4 | view · |
| 4 | 2025-03-28 | 4 | view · |
| 4 | 2025-03-28 | 4 | view · |
About GMED
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offer…
Options picks · GMED
ITM + OTM ideas from the latest scanLoading…
Congress trades · GMED
STOCK Act disclosuresLoading…
SEC filings & insiders · GMED
EDGAR · liveLoading…
Holders · GMED
Institutions & insider activityLoading…